Abstract
For the past 15 years, measurements of cerebral blood flow as an indicator of neuronal activity have been used to gain a better understanding of the neural basis of motor and cognitive deficits in Parkinson’s disease. The initial studies, using positron emission tomography, yielded results in keeping with the hypothesis that symptoms result from excessive cortical inhibition from cortico-striatal loops. However, subsequent studies with functional magnetic resonance imaging (fMRI) have shown that specific aspects of the paradigms used, such as the need to pay attention to one’s movements, have a significant impact on activation patterns, which may complicate the interpretation of results. Functional neuroimaging has also been used to investigate the causes of cognitive impairment in Parkinson’s disease. While some studies implicate dopamine loss in striatum, more recent investigations using anatomical MRI to measure cortical atrophy suggest that some cognitive deficits are attributable to direct cortical involvement by the disease.
Similar content being viewed by others
References
Alexander GE, DeLong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357–381
Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders [see comments]. Trends Neurosci 12:366– 375
Haber SN, Fudge JL, McFarland NR (2000) Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci 20:2369–2382
Parent A (1990) Extrinsic connections of the basal ganglia. Trends Neurosci 13:254–258
Moore RY, Bloom FE (1978) Central catecholamine neuron systems: anatomy and physiology of the dopamine systems. Annu Rev Neurosci 1:129–169
Sesack SR, Pickel VM (1992) Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neurol 320:145–160
Wickens J, Kotter R (1995) Cellular models of reinforcement. In: Houk JC, Davis JL and Beiser DG (eds) Models of information processing in the basal ganglia. Cambridge, MA: MIT Press, pp 187–214
Whitton PS (1997) Glutamatergic control over brain dopamine release in vivo and in vitro. Neurosci Biobehav Rev 21:481–488
Raichle ME (1987) Circulatory and metabolic correlates of brain function in normal humans. In: Mountcastle VB (ed) Handbook of physiology, sect 1, vol 5: the nervous system. Bethesda: American Physiological Society, pp 643–674
Talairach J, Tournoux P (1988) Co-planar stereotaxic atlas of the human brain. Stuttgart: Thieme
Worsley KJ, Liao CH, Aston J, et al. (2002) A general statistical analysis for fMRI data. Neuroimage. 15:1–15
Ogawa S, Lee TM, Kay AR, Tank DW (1990) Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci USA 87:9868–9872
Logothetis NK (2002) The neural basis of the blood-oxygen-level-dependent functional magnetic resonance imaging signal. Philos Trans R Soc Lond B Biol Sci 357:1003–1037
Logothetis NK, Pfeuffer J (2004) On the nature of the BOLD fMRI contrast mechanism. Magn Reson Imaging 22:1517–1531
Waldvogel D, van Gelderen P, Muellbacher W, Ziemann U, Immisch I, Hallett M (2000) The relative metabolic demand of inhibition and excitation. Nature 406:995–998
Shmuel A, Augath M, Oeltermann A, Logothetis NK (2006) Negative functional MRI response correlates with decreases in neuronal activity in monkey visual area V1. Nat Neurosci 9:569–577
Jech R, Urgosik D, Tintera J, et al. (2001) Functional magnetic resonance imaging during deep brain stimulation: a pilot study in four patients with Parkinson’s disease. Mov Disord 16:1126–1132
Ashburner J, Friston KJ (2000) Voxel-based morphometry—the methods. Neuroimage 11:805–821
Scherfler C, Schocke MF, Seppi K, et al. (2006) Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson’s disease. Brain 129:538–542
Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211
Rascol O, Sabatini U, Chollet F, et al. (1992) Supplementary and primary sensory motor area activity in Parkinson’s disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine. Arch Neurol 49:144–148
Playford ED, Jenkins IH, Passingham, RE, Nutt J, Frackowiak RS, Brooks DJ (1992) Impaired mesial frontal and putamen activation in Parkinson’s disease: a positron emission tomography study. Ann Neurol 32:151–161
Jenkins IH, Fernandez W, Playford ED, et al. (1992) Impaired activation of the supplementary motor area in Parkinson’s disease is reversed when akinesia is treated with apomorphine. Ann Neurol 32:749–757
Jahanshahi M, Jenkins IH, Brown RG, Marsden CD, Passingham RE, Brooks DJ (1995) Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson’s disease subjects. Brain 118:913–933
Grafton ST, Waters C, Sutton J, Lew MF, Couldwell W (1995) Pallidotomy increases activity of motor association cortex in Parkinson’s disease: a positron emission tomographic study. Ann Neurol 37:776–783
Samuel M, Ceballos Baumann AO, Turjanski N, et al. (1997) Pallidotomy in Parkinson’s disease increases supplementary motor area and prefrontal activation during performance of volitional movements An H2O PET study. Brain 120:1301–1313
Limousin P, Greene J, Pollak P, Rothwell J, Benabid AL, Frackowiak R (1997) Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson’s disease. Ann Neurol 42:283–291
Ceballos-Baumann AO, Boecker H, Bartenstein P, et al. (1999) A positron emission tomographic study of subthalamic nucleus stimulation in Parkinson disease: enhanced movement-related activity of motor-association cortex and decreased motor cortex resting activity. Arch Neurol 56:997–1003
Strafella AP, Dagher A, Sadikot A (2003) Cerebral blood flow changes induced by subthalamic stimulation in Parkinson’s disease. Neurology 60:1039–1042
Fukuda M, Mentis M, Ghilardi MF, et al. (2001) Functional correlates of pallidal stimulation for Parkinson’s disease. Ann Neurol 49:155–164
Thobois S, Dominey P, Decety J, Pollak P, Gregoire MC, Broussolle E (2000) Overactivation of primary motor cortex is asymmetrical in hemiparkinsonian patients. Neuroreport 11:785–789
Samuel M, Ceballos-Baumann AO, Blin J, et al. (1997) Evidence for lateral premotor and parietal overactivity in Parkinson’s disease during sequential and bimanual movements. A PET study. Brain 120:963–976
Wise SP, Boussaoud D, Johnson PB, Caminiti R (1997) Premotor and parietal cortex: corticocortical connectivity and combinatorial computations. Annu Rev Neurosci 20:25–42
Dum RP, Strick PL (2002) Motor areas in the frontal lobe of the primate. Physiol Behav 77:677–682
Haslinger B, Erhard P, Kampfe N, et al. (2001) Event-related functional magnetic resonance imaging in Parkinson’s disease before and after levodopa. Brain 124:558–570
Hanakawa T, Fukuyama H, Katsumi Y, Honda M., Shibasaki H (1999) Enhanced lateral premotor activity during paradoxical gait in Parkinson’s disease. Ann Neurol 45:329–336
Peters S, Suchan B, Rusin J, et al. (2003) Apomorphine reduces BOLD signal in fMRI during voluntary movement in Parkinsonian patients. Neuroreport 14:809–812
Sabatini U, Boulanouar K, Fabre N, et al. (2000) Cortical motor reorganization in akinetic patients with Parkinson’s disease: a functional MRI study. Brain 123:394–403
Middleton FA, Strick PL (2000) Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res Brain Res Rev 31:236–250
Buhmann C, Glauche V, Sturenburg HJ, Oechsner M, Weiller C, Buchel C (2003) Pharmacologically modulated fMRI-cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients. Brain 126:451–461
Petrides M (1994) Frontal lobes and working memory: evidence from investigations of the effects of cortical excisions in nonhuman primates. In: Boller F and Grafman J (eds) Handbook of neuropsychology. Amsterdam: Elsevier, pp 59–82
Owen AM (1997) The functional organization of working memory processes within human lateral frontal cortex: the contribution of functional neuroimaging. Eur J Neurosci 9:1329–1339
Freund HJ (1987) Abnormalities of motor behavior after cortical lesions in humans. In: Mountcastle VB and Plum F (eds) Handbook of physiology, section 1, the nervous system. Bethesda, MD: American Physiological Society, pp 768–810
Goldman-Rakic PS (1987) Circuitry of primate prefrontal cortex and regulation of behavior by representational memory. In: Mountcastle VB and Plum F (eds) Handbook of physiology, section 1, the nervous system. Bethesda, MD: American Physiological Society, pp 373–418
Catalan MJ, Ishii K, Honda M, Samii A, Hallett M (1999) A PET study of sequential finger movements of varying length in patients with Parkinson’s disease. Brain 122:483–495
Samuel M, Ceballos-Baumann AO, Boecker H, Brooks DJ (2001) Motor imagery in normal subjects and Parkinson’s disease patients: an H215O PET study. Neuroreport 12:821–828
Boecker H, Dagher A, Ceballos-Baumann AO, et al. (1998) Role of the human rostral supplementary motor area and the basal ganglia in motor sequence control: investigations with H2 15O PET [published erratum appears in J Neurophysiol 1998 Jun; 79(6):3301]. J Neurophysiol 79:1070–1080
Rowe J, Stephan KE, Friston K, Frackowiak R, Lees A, Passingham R (2002) Attention to action in Parkinson’s disease: impaired effective connectivity among frontal cortical regions. Brain 125:276–289
Dirnberger G, Frith CD, Jahanshahi M (2005) Executive dysfunction in Parkinson’s disease is associated with altered pallidal–frontal processing. Neuroimage 25:588–599
Schrag A, Jahanshahi M, Quinn N (2000) What contributes to quality of life in patients with Parkinson’s disease? J Neurol Neurosurg Psychiatry 69:308–312
Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB (2004) Effect of psychiatric and other nonmotor symptoms on disability in Parkinson’s disease. J Am Geriatr Soc 52:784–788
Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sorensen P (2001) Risk of dementia in Parkinson’s disease: a community-based, prospective study. Neurology 56:730–736
Dubois B, Boller F, Pillon B, Agid Y (1991) Cognitive deficits in Parkinson’s disease. In: Boller F and Grafman J (eds) Handbook of neuropsychology. New York: Elsevier Science, pp 195–240
Owen AM, James M, Leigh PN, et al. (1992) Fronto-striatal cognitive deficits at different stages of Parkinson’s disease. Brain 115:1727–1751
Monchi O, Petrides M, Petre V, Worsley K, Dagher A (2001) Wisconsin Card Sorting revisited: distinct neural circuits participating in different stages of the task identified by event-related fMRI. J Neurosci 21:7733–7741
Dagher A, Owen AM, Boecker H, Brooks DJ (1999) Mapping the network for planning: a correlational PET activation study with the Tower of London task. Brain 122:1973–1987
Dagher A, Owen AM, Boecker H, Brooks DJ (2001) The role of the striatum and hippocampus in planning: a PET activation study in Parkinson’s disease. Brain 124:1020–1032
Owen AM, Doyon J, Dagher A, Sadikot A, Evans AC (1998) Abnormal basal ganglia outflow in Parkinson’s disease identified with PET. Implications for higher cortical functions. Brain 121:949–965
Bruck A, Portin R, Lindell A, et al. (2001) Positron emission tomography shows that impaired frontal lobe functioning in Parkinson’s disease is related to dopaminergic hypofunction in the caudate nucleus. Neurosci Lett 311:81–84
Marie RM, Barre L, Dupuy B, Viader F, Defer G, Baron JC (1999) Relationships between striatal dopamine denervation and frontal executive tests in Parkinson’s disease. Neurosci Lett 260:77–80
Cools R, Stefanova E, Barker RA, Robbins TW, Owen AM (2002) Dopaminergic modulation of high-level cognition in Parkinson’s disease: the role of the prefrontal cortex revealed by PET. Brain 125:584–594
Mattay VS, Tessitore A, Callicott JH, et al. (2002) Dopaminergic modulation of cortical function in patients with Parkinson’s disease. Ann Neurol 51:156–164
Sawaguchi T, Matsumura M, Kubota K (1990) Catecholaminergic effects on neuronal activity related to a delayed response task in monkey prefrontal cortex. J Neurophysiol 63:1385–1400
Mink JW (1996) The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol 50:381–425
Hallett M (1993) Physiology of basal ganglia disorders: an overview. Can J Neurol Sci 20:177–183
Lewis SJ, Dove A, Robbins TW, Barker RA, Owen AM (2003) Cognitive impairments in early Parkinson’s disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci 23:6351–6356
Monchi O, Petrides M, Doyon J, Postuma RB, Worsley K, Dagher A (2004) Neural bases of set-shifting deficits in Parkinson’s disease. J Neurosci 24:702–710
Monchi O, Petrides M, Mejia-Constain B, Strafella AP (2007) Cortical activity in Parkinson’s disease during executive processing depends on striatal involvement. Brain 130:233–244
Gotham AM, Brown RG, Marsden CD (1988) ‘Frontal’ cognitive function in patients with Parkinson’s disease ‘on’ and ‘off’ levodopa. Brain 111:299–321
Kish SJ, Shannak K, Hornykiewicz O (1988) Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson’s disease. Pathophysiologic and clinical implications. N Engl J Med 318:876–880
Cools R, Lewis SJ, Clark L, Barker RA, Robbins TW (2007) l-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson’s disease. Neuropsychopharmacology 32:180–189
Moody TD, Bookheimer SY, Vanek Z, Knowlton BJ (2004) An implicit learning task activates medial temporal lobe in patients with Parkinson’s disease. Behav Neurosci 118:438–442
Packard MG, Hirsh R, White NM (1989) Differential effects of fornix and caudate nucleus lesions on two radial maze tasks: evidence for multiple memory systems. J Neurosci 9:1465–1472
Grossman M, Cooke A, DeVita C, et al. (2003) Grammatical and resource components of sentence processing in Parkinson’s disease: an fMRI study. Neurology 60:775–781
Gusnard DA, Raichle ME (2001) Searching for a baseline: functional imaging and the resting human brain. Nat Rev Neurosci 2: 685–694
Scatton B, Javoy-Agid F, Rouquier L, Dubois B, Agid Y (1983) Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson’s disease. Brain Res 275:321–328
Asahina M, Suhara T, Shinotoh H, Inoue O, Suzuki K, Hattori T (1998) Brain muscarinic receptors in progressive supranuclear palsy and Parkinson’s disease: a positron emission tomographic study. J Neurol Neurosurg Psychiatry 65:155–163
Kuhl DE, Minoshima S, Fessler JA, et al. (1996) In vivo mapping of cholinergic terminals in normal aging, Alzheimer’s disease, and Parkinson’s disease. Ann Neurol 40:399–410
Hilker R, Thomas AV, Klein JC, et al. (2005) Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology 65:1716–1722
Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA (2003) Parkinson’s disease is associated with hippocampal atrophy. Mov Disord 18:784–790
Riekkinen P Jr, Kejonen K, Laakso MP, Soininen H, Partanen K, Riekkinen M (1998) Hippocampal atrophy is related to impaired memory, but not frontal functions in non-demented Parkinson’s disease patients. Neuroreport 9:1507–1511
Nagano-Saito A, Washimi Y, Arahata Y, et al. (2005) Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 64:224–229
Burton EJ, McKeith IG, Burn DJ, Williams ED, O’Brien JT (2004) Cerebral atrophy in Parkinson’s disease with and without dementia: a comparison with Alzheimer’s disease, dementia with Lewy bodies and controls. Brain 127:791–800
Summerfield C, Junque C, Tolosa E, et al. (2005) Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch Neurol 62:281–285
Kassubek J, Juengling FD, Hellwig B, Spreer J, Lucking CH (2002) Thalamic gray matter changes in unilateral Parkinsonian resting tremor: a voxel-based morphometric analysis of 3-dimensional magnetic resonance imaging. Neurosci Lett 323:29–32
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dagher, A., Nagano-Saito, A. Functional and Anatomical Magnetic Resonance Imaging in Parkinson’s Disease. Mol Imaging Biol 9, 234–242 (2007). https://doi.org/10.1007/s11307-007-0089-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-007-0089-0